Search database
Filter
536
Featured
Language
Document type
377
72
30
29
12
6
6
2
2
Countries
36
18
16
14
13
12
11
10
10
10
10
9
9
9
8
8
8
8
8
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
Authors & Publishers
31
31
28
11
9
9
8
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
273
54
25
16
13
10
5
1
1
Toolboxes
91
28
24
19
16
14
13
13
10
8
7
6
6
6
5
4
4
4
3
1
1
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection HIV Treatment
HIV Treatment

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO
Accessed: 19.10.2019
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches. HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i ... more
PQDx 0198-071-00 WHO PQDx PR April/2016, version 2.0

SAVE Advocacy Strategy - The Kenyan Case Study

Inerela + Kenya (International Network of Religious Leaders Living with or personally affected by HIV - Kenya Chapter); Christian aid (2019) C2
Accessed: 17.11.2019

Act Toolkit 2.0 - Advocacy for community Treatment

B. Killingo; T. Taro; E. Whyle; et al. ITPC (International Treatment Preparedness Coalition) (2016) C2
Strengthening Community responses to HIv Treatment and Prevention

A Path to Policy - A Blueprint for Community Engagement and Advocacy

M. Allen; E. McCloskey; J. M. Scofield et al. NASTAD (National Alliance of State & Territorial AIDS Directors) (2014) C2
Sept 2014 / nastad.org
Le Ministère de la Santé (MS), dans le cadre de la démarche qualité au niveau du secteur, s’est engagé depuis quelques années dans la normalisation des activités par l’élaboration et la mise en place de documents normatifs. C’est le cas du présent document de politique, normes et proc ... more
International Journal of Infectious Diseases 80 (2019) 10–15 journal homepage: www.elsevier.com/locate/ijid
Research Article PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016

Adherence to Treatment for HIV A Training Curriculum for Counselors - Participant Manual

F. Saini; Dr. V. R. Kandula; G. Venugopal Engender Health Society (Improving Women's Health Worldwide); CII Confederation of Indian Industry; Population Foundation of India; et al. (2006) C2
Accessed: 27.11.2019

Directrices unificadas sobre el uso de los antirretrovirales para el tratamiento y la prevención de la infección por el VIH

Organización Panamericana de la Salud; Organización Mundial de la Salud (Americas) (2018) C_WHO
Recomendaciones para un enfoque de salud pública Segunda edición 2016